NPR News: Nuclear power push ramps up uranium mill — and tribal health concerns

Nuclear power push ramps up uranium mill — and tribal health concerns
Federal efforts to revive uranium mining in the West and decrease reliance on Russian uranium raise concerns about drinking water for tribal communities reckoning with the industry's deadly legacy.

Read more on NPR

NPR News: Researchers have successfully used AI to create brand new viruses

Researchers have successfully used AI to create brand new viruses
For the first time, researchers have used artificial intelligence to generate novel viruses in a laboratory setting, according to a paper in the journal Science.

Read more on NPR

NPR News: Who really needs testosterone?

Who really needs testosterone?
The military plans to start screening service members for low testosterone, and social media is overflowing with claims about testosterone therapy. But who actually needs it?

Read more on NPR

NPR News: Solar eclipse to occur next week. Here is what to know

Solar eclipse to occur next week. Here is what to know
It will be visible in parts of the U.S. on Wednesday.

Read more on NPR

NPR News: Science reporter on how evidence based reporting can be a parent's best friend

Science reporter on how evidence based reporting can be a parent's best friend
NPR's Rob Schmitz talks to reporter Maria Godoy about how parents can wade through the noise and opinions to find information to help keep their kids healthy.

Read more on NPR

NPR News: Monty Roberts, who trained horses through trust, dies at 91

Monty Roberts, who trained horses through trust, dies at 91
The internationally acclaimed horseman defied the conventional method of breaking horses and developed his own gentler approach — based on horses' non-verbal language. Roberts spoke with Fresh Air in 1997.

Read more on NPR

NPR News: Kalshi and Polymarket bets on clinical trials criticized as 'ghastly'

Kalshi and Polymarket bets on clinical trials criticized as 'ghastly'
Researchers warn betting on clinical trials could incentivize insider trading and interfere with drug development. But Kalshi and Polymarket say they provide valuable information to patients.

Read more on NPR